Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma

Overview of attention for article published in Hematological Oncology, November 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 6 X users

peer_reviews: 1 peer review site

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 12,930 followers.

RT @frbertoni: Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma - Desai - 2023 - Hema…

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma - Desai - 2023 - Hematological Oncology https://t.co/TMSbQODTbe

Hematological Oncology: Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma https://t.co/KnvQyVpkhM アイオワ大学/メイヨークリニック373例。再発治療抵抗性だとCOOは予後と関係なくなるらしい。

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.